Selim Corbacioglu
Impact in
- Hematology top 0.2%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Genetics top 0.5%
- Hemoglobinopathies and Related Disorders
- Virus-based gene therapy research
Papers in
- Hematology 108
- Hematopoietic Stem Cell Transplantation 84
- Acute Myeloid Leukemia Research 39
- Genetics 46
- Hemoglobinopathies and Related Disorders 36
- Co-authors
- Mohamad Mohty (13 shared papers)John Andrew Snowden (10 shared papers)Régis Peffault de Latour (9 shared papers)Ibrahim Yakoub‐Agha (7 shared papers)Christian Chabannon (8 shared papers)Nicolaus Martin Kröger (6 shared papers)Paul Gerard Guy Richardson (14 shared papers)Rafael F. Duarte (6 shared papers)
In The Last Decade
Selim Corbacioglu
187 papers receiving 9.6k citations
Selim Corbacioglu's Hit Papers
Peers
Comparison fields: 5 of 132
- Hematology 4.0k
- Genetics 1.6k
- Oncology 2.0k
- Transplantation 173
- Immunology 1.3k
Countries citing papers authored by Selim Corbacioglu
This map shows the geographic impact of Selim Corbacioglu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Selim Corbacioglu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Selim Corbacioglu more than expected).
Fields of papers citing papers by Selim Corbacioglu
This network shows the impact of papers produced by Selim Corbacioglu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Selim Corbacioglu. The network helps show where Selim Corbacioglu may publish in the future.
Co-authors
The 25 scholars most cited alongside Selim Corbacioglu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 200 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia Hit paper breakdown → | 2020 | 1386 |
| 2 | Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation Hit paper breakdown → | 2016 | 430 |
| 3 | Loss of Interleukin-10 Signaling and Infantile Inflammatory Bowel Disease: Implications for Diagnosis and Therapy Hit paper breakdown → | 2012 | 392 |
| 4 | Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA) Hit paper breakdown → | 2021 | 325 |
| 5 | 2012 | 306 | |
| 6 | 2015 | 305 | |
| 7 | 2019 | 299 | |
| 8 | Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years Hit paper breakdown → | 2021 | 290 |
| 9 | 2010 | 282 | |
| 10 | 2019 | 259 | |
| 11 | Exagamglogene Autotemcel for Severe Sickle Cell Disease Hit paper breakdown → | 2024 | 257 |
| 12 | 2017 | 255 | |
| 13 | Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022 Hit paper breakdown → | 2022 | 243 |
| 14 | Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study Hit paper breakdown → | 2020 | 239 |
| 15 | 2003 | 203 | |
| 16 | 2003 | 171 | |
| 17 | 2020 | 160 | |
| 18 | 2021 | 158 | |
| 19 | 2020 | 146 | |
| 20 | 2019 | 135 |
About Selim Corbacioglu
Selim Corbacioglu is a scholar working on Hematology, Genetics, Pediatrics, Perinatology and Child Health, Oncology and Immunology, having authored 200 papers that have together received 9.8k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (84 papers), Acute Myeloid Leukemia Research (39 papers), Hemoglobinopathies and Related Disorders (36 papers), Acute Lymphoblastic Leukemia research (21 papers), Childhood Cancer Survivors' Quality of Life (16 papers), CAR-T cell therapy research (14 papers), Neutropenia and Cancer Infections (12 papers) and Prenatal Screening and Diagnostics (12 papers). The work is most often cited by research in Hematology (4.0k citations), Genetics (1.6k citations), Oncology (2.0k citations), Transplantation (173 citations) and Immunology (1.3k citations). Selim Corbacioglu has collaborated with scholars based in Germany, France and Italy. Frequent co-authors include Mohamad Mohty, John Andrew Snowden, Régis Peffault de Latour, Ibrahim Yakoub‐Agha, Christian Chabannon, Nicolaus Martin Kröger, Paul Gerard Guy Richardson, Rafael F. Duarte, Harry Dolstra and Arjan C. Lankester. Their work appears in journals such as Bone Marrow Transplantation, Blood, Transplantation and Cellular Therapy, Haematologica and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.